On a case-by-case basis, the Institute for Regenerative Cures partners with teams of investigators to assist with the development of pre-IND and IND applications to the U.S. Food and Drug Administration. Institute staff has exceptional skill and experience with gene-modified adult stem cells. Hourly consultation rates are available.

Contact: William (Bill) Gruenloh   wjgruenloh@ucdavis.edu